GETTING MY BLOCK PAIN RECEPTORS WITH PROLEVIATE TO WORK

Owning identified the palmitoylation motif of APLNR, we created a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web site together with morphine, can inhibit the development of NCP, which includes pain incidence, microglial activation, and in